01-10-2019 | Infliximab | Case report
Infliximab
Infusion reaction: case report
Published in:
Reactions Weekly
|
Issue 1/2019
Login to get access
Excerpt
In a retrospective study involving 22 patients, a patient [age and sex not stated] was described, who developed infusion reaction following treatment with infliximab for allograft dysfunction. The patient, who had undergone intestinal transplantation and had allograft dysfunction started receiving treatment with infliximab infusion 5 mg/kg/dose [route not stated]. Subsequently, the patient developed infusion reaction. As a result, the patient's therapy with infliximab was discontinued [duration of treatment to reaction onset and outcome not stated]. …